CRIS Current Research Information System

BERTUZZO, VALENTINA ROSA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.713
AS - Asia 3.591
EU - Europa 2.435
AF - Africa 282
SA - Sud America 166
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.194
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.653
VN - Vietnam 1.146
SG - Singapore 950
CN - Cina 641
IT - Italia 497
GB - Regno Unito 449
HK - Hong Kong 375
SE - Svezia 351
DE - Germania 328
IN - India 179
FR - Francia 154
BR - Brasile 117
RU - Federazione Russa 112
IE - Irlanda 104
CI - Costa d'Avorio 93
NL - Olanda 90
FI - Finlandia 65
UA - Ucraina 61
TG - Togo 59
CH - Svizzera 47
JP - Giappone 45
KR - Corea 44
ZA - Sudafrica 41
SC - Seychelles 40
CA - Canada 34
PH - Filippine 30
TR - Turchia 29
BG - Bulgaria 27
EE - Estonia 27
NG - Nigeria 27
JO - Giordania 26
ES - Italia 25
BE - Belgio 24
TH - Thailandia 22
AR - Argentina 21
AT - Austria 21
MX - Messico 17
TW - Taiwan 17
BD - Bangladesh 15
PK - Pakistan 15
PL - Polonia 15
EC - Ecuador 14
ID - Indonesia 12
IQ - Iraq 10
EG - Egitto 7
MK - Macedonia 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
CL - Cile 6
GR - Grecia 5
AU - Australia 4
MY - Malesia 4
PY - Paraguay 4
RO - Romania 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
IR - Iran 3
MA - Marocco 3
NO - Norvegia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
CO - Colombia 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LY - Libia 2
RS - Serbia 2
SM - San Marino 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
DO - Repubblica Dominicana 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
LT - Lituania 1
LV - Lettonia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.194
Salva come PNG Salva come JPEG
Città #
Singapore 656
Ashburn 421
Southend 349
Hong Kong 347
Chandler 330
Fairfield 274
Dong Ket 239
Ho Chi Minh City 218
Hanoi 207
Houston 198
San Jose 168
Woodbridge 146
Wilmington 136
Santa Clara 121
Ann Arbor 120
Princeton 117
Cambridge 113
Seattle 107
Dublin 104
Bologna 97
Abidjan 93
Los Angeles 90
Beijing 89
Boardman 83
Hefei 70
Lomé 59
Lauterbourg 57
Helsinki 49
New York 45
Da Nang 40
Bern 39
Tokyo 39
Westminster 39
Berlin 35
Munich 35
Buffalo 34
Council Bluffs 34
Haiphong 34
Nanjing 31
Florence 29
Seoul 29
Dallas 27
Sofia 27
Medford 26
Amman 25
Jinan 25
Brussels 24
Chicago 24
Frankfurt am Main 24
Bremen 23
Redondo Beach 23
Jacksonville 20
Milan 20
Padova 20
Rome 20
São Paulo 20
Abeokuta 19
Redmond 19
Shenyang 19
Turin 18
Phoenix 15
Saint Petersburg 15
Changsha 14
Nuremberg 14
Biên Hòa 13
Falls Church 13
Hải Dương 13
Amsterdam 12
Ankara 12
London 12
San Diego 12
Thái Bình 12
Tianjin 12
Bursa 11
Des Moines 11
Hyderabad 11
Shanghai 11
Turku 11
Basingstoke 10
Bühl 10
Düsseldorf 10
Guangzhou 10
Portland 10
Toronto 10
Vienna 10
Can Tho 9
Nanchang 9
Olalla 9
Pune 9
San Francisco 9
Bengaluru 8
Dearborn 8
Hebei 8
Kyiv 8
Modena 8
Montreal 8
Nottingham 8
Salt Lake City 8
Baghdad 7
Bangkok 7
Totale 6.361
Salva come PNG Salva come JPEG
Nome #
TRAPIANTO DI FEGATO CON TROMBOSI PORTALE COMPLETA: ESPERIENZA DI 11 CASI TRATTATI MEDIANTE ANASTOMOSI TRA LA VENA PORTA DEL GRAFT E LA VARICE GASTRICA DEL RICEVENTE 320
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 278
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 269
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 252
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 246
Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-A randomized clinical trial 229
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 207
Abdominal wall defect repair with biological prosthesis in transplanted patients: single center retrospective analysis and review of the literature 205
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 202
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 202
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 197
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 192
The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation: An Italian Cohort Study 190
Impact of preoperative infection on outcome after liver transplantation 188
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 186
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 185
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 182
LIVER TRANSPLANTATION IN RECIPIENTS WITH HISTORY OF AIDS-DEFINING CLINICAL CONDITIONS: IS IT POSSIBLE TO EXTEND THE INDICATIONS? 177
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 176
DOPPI TRAPIANTI DI RENE MONOLATERALI CON RICOSTRUZIONI VASCOLARI A BANCO IN GRFAFT CON VASI MULTIPLI E RICEVENTI SEVERAMENTE ATEROMASICI 176
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function 175
RESISTENZA AL FLUSSO E MARKERS METABOLICI COME STRUMENTI DI VALUTAZIONE D’ORGANO PER IL TRAPIANTO DI RENI MARGINALI: STUDIO PROSPETTICO ITALIANO SULLA PERFUSIONE IPOTERMICA OSSIGENATA 174
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. 168
Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era 168
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 167
Comments to “Long-Term Survival Benefit and Potential for Cure After R1 Resection for Colorectal Liver Metastases” 166
Double Single-Side Kidney Transplants With Bench Vascular Reconstruction: A Further Challenge Beyond the Marginality Without Future Preclusions 162
RANDOMIZED TRIAL ON HYPOTHERMIC OXYGENATED PERFUSION VS STATIC COLD STORAGE IN LIVER TRANSPLANTATION FROM EXTENDED CRITERIA DONORS: INTERIM ANALYSIS 162
Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas 161
MATCH DONATORE-RICEVENTE NEL TRAPIANTO DI FEGATO: COME MIGLIORARE LA SOPRAVVIVENZA NEI PAZIENTI CON MELD ELEVATO NELL'ERA DEI DONATORI MARGINALI 160
Alungamento dei vasi renali mediante allograft vascolari criopreservati: è possibile ottimizzare le problematiche tecniche nel trapianto da vivente con graft destri o vascolarizzazione anomala? 157
Author Correction: Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors: First Italian Clinical Trial (Scientific Reports, (2020), 10, 1, (6063), 10.1038/s41598-020-62979-9) 156
Circulating miR-122-5p, miR-92a-3p, and miR-18a-5p as Potential Biomarkers in Human Liver Transplantation Follow-Up 155
Renal Vessel Extension With Cryopreserved Vascular Grafts: Overcoming Surgical Pitfalls in Living Donor Kidney Transplant 155
HCV ED ETA' AVANZATA SONO LIMITI SUPERABILI NELLA DONAZIONE DI RENE DA VIVENTE 154
PORTO-CAVAL SHUNT IN SPLIT LIVER TRASPLANTATION: IS THERE ANY TIME LIMIT TO CLOSE IT? 154
Survival Benefit After Liver Transplantation: A Single European Center Experience 152
DOWN-STAGING TREATMENT IMPROVEMENTS CHANGED THE PARADIGM OF LIVER TRANSPLANTATION FOR HCC 149
17. Other Malignant Primary Tumors of the Liver 146
SHUNT PORTO-CAVALE IN TRAPIANTO SPLIT DI FEGATO: NECESSARIO SEMPRE CHIUDERLO E QUANDO? 146
Long-term antiviral treatment for recurrent hepatitis C after liver transplantation. 145
Can Positive Resection Margin of Intra-hepatic Cholangiocarcinoma Still Provide a Survival Benefit over Systemic Chemotherapy? 142
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 140
null 135
trapianto di rene da donatore marginale. Correlazione tra tipologia di lesione e prognosi a medio-lungo termine 131
Combined abdominal transplantation: Liver-kidney 130
Preliminary experience of sequential use of normothermic and hypothermic oxygenated perfusion for donation after circulatory death kidney with warm ischemia time over the conventional criteria - a retrospective and observational study 128
IL RUOLO DELLA BIOPSIA RENALE NEL DONATORE DI RENE 128
Trapianto renale da donatore diabetico: modificazione dei pattern istologici di nefropatia diabetica 123
Reply 122
NEGATIVE PRESSURE TREATMENT OF WOUND AND ABDOMINAL INFECTIONS AFTER SOLID ORGAN TRASPLANTATION: BOLOGNA TRANSPLANT CENTER EXPERIENCE. 116
null 115
TRAPIANTO EPATICO IN PAZIENTI CON STORIA DI AIDS: È POSSIBILE ALLARGARE LE INDICAZIONI ALL’INTERVENTO? 115
Peritoneal seeding from appendiceal carcinoma: A case report and review of the literature 112
STUDIO MONOCENTRICO RANDOMIZZATO SULLA PERFUSIONE IPOTERMICA OSSIGENATA VS. CONSERVAZIONE STATICA NEL TRAPIANTO DI FEGATO CON DONATORI CON CRITERI ESTESI: ANALISI AD INTERIM PRELIMINARE 110
Liver transplantation for hepatocellular carcinoma: Role of inflammatory and immunological state on recurrence and prognosis 106
Retransplantation (causes, outcome) 102
Pregnant woman saved with liver transplantation from acute liver failure due to hepatitis E virus 101
LA PERFUSIONE IPOTERMICA OSSIGENATA PUÒ PERMETTERE DI PROLUNGARE L'ISCHEMIA FREDDA NEL TRAPIANTO DI FEGATO CON ORGANI DA DONATORI ANZIANI? 101
Third-party bone marrow-derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial 100
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients. 95
The role of cold ischemia time and hypothermic perfusion in predicting early hepatocellular carcinoma recurrences after liver transplantation 91
PHYSIOLOGICAL RECONSTRUCTIONS IN LIVER TRANSPLANTATION WITH NON-TUMORAL EXTENDED PORTAL VEIN THROMBOSIS: RESULTS AT TWO LARGE VOLUME CENTRES 78
UN PECULIARE CASO DI “UNEXPECTED DONOR-DERIVED INFECTION” DA E.COLI ESBL MANIFESTATASI COME ARTERITE CON UGUALE EVOLUZIONE NEI RENI GEMELLI 76
HCV AND KIDNEY TRANSPLANTATION: PUSHING THE LIMITS FOR LIVING DONATION 59
Hypothermic Oxygenated Machine Perfusion in Liver and Kidney Transplantation of Extended Criteria Donors: A Phase-1 of Clinical Trial 59
PRE -TRANSPLANT IN SITU KIDNEY BIOPSY TO REDUCE COLD ISCHEMIA TIME AND TO IMPROVE TRANSPLANT OUTCOME: MONOCENTRIC RETROSPECTIVE ANALYSIS 53
THE USE OF CRYOPRESERVED VASCULAR HOMOGRAFTS IN LIVING DONOR KIDNEY TRANSPLANTATION 29
Totale 10.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.700
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021406 0 0 0 0 0 0 0 0 0 46 40 320
2021/20221.139 101 34 54 82 105 42 20 110 50 92 244 205
2022/20231.499 124 211 64 190 138 137 50 100 266 43 104 72
2023/2024433 46 94 37 37 29 86 11 15 7 24 19 28
2024/20251.551 98 237 143 109 181 72 84 65 29 138 101 294
2025/20263.606 338 263 253 258 392 230 741 97 755 279 0 0
Totale 10.388